Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FDRCQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,663
Award facts
- Contract value 100% obligated
- $16,663.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,663.20 by the Defense Logistics Agency on September 25, 2025, for the supply of Nexplanon 68 mg implants. The contract carries an ultimate completion date of October 17, 2025, and represents a direct fulfillment order with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion master agreement effective through November 2026 that authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group demonstrates substantial experience delivering diverse medical products to military health systems nationwide. The Nexplanon implant—a subdermal contraceptive device—falls within the company's established portfolio of pharmaceutical deliveries to DLA, which encompasses prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's consistent success in securing delivery orders reflects its competitive positioning and operational capabilities as a woman-owned small business serving the defense healthcare procurement market.
Quick answers
Who was awarded contract SPE2DB25FDRCQ?
SPE2DB25FDRCQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FDRCQ worth?
The government has obligated $16,663 on SPE2DB25FDRCQ.
Is contract SPE2DB25FDRCQ an order under another contract?
Yes. SPE2DB25FDRCQ is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDRCQ competed?
The extent of competition for SPE2DB25FDRCQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award